| __timestamp | Lantheus Holdings, Inc. | Novo Nordisk A/S |
|---|---|---|
| Wednesday, January 1, 2014 | 72429000 | 26760000000 |
| Thursday, January 1, 2015 | 78634000 | 32169000000 |
| Friday, January 1, 2016 | 75374000 | 32339000000 |
| Sunday, January 1, 2017 | 92157000 | 32124000000 |
| Monday, January 1, 2018 | 93326000 | 33313000000 |
| Tuesday, January 1, 2019 | 103132000 | 35830000000 |
| Wednesday, January 1, 2020 | 110171000 | 36886000000 |
| Friday, January 1, 2021 | 218817000 | 41058000000 |
| Saturday, January 1, 2022 | 233827000 | 50684000000 |
| Sunday, January 1, 2023 | 267194000 | 61598000000 |
| Monday, January 1, 2024 | 67377000000 |
Unveiling the hidden dimensions of data
In the competitive landscape of the pharmaceutical industry, managing Selling, General, and Administrative (SG&A) expenses is crucial for profitability. Novo Nordisk A/S, a global leader in diabetes care, and Lantheus Holdings, Inc., a prominent player in diagnostic imaging, offer a fascinating comparison. From 2014 to 2023, Novo Nordisk's SG&A expenses have surged by approximately 130%, reflecting its expansive global operations. In contrast, Lantheus Holdings has seen a more modest increase of around 270%, indicating a strategic focus on cost efficiency. Despite Novo Nordisk's larger scale, Lantheus's ability to maintain a leaner SG&A structure could be a testament to its agile management. As the industry evolves, these trends highlight the importance of balancing growth with cost control.
SG&A Efficiency Analysis: Comparing Novo Nordisk A/S and Viatris Inc.
Novo Nordisk A/S vs Xenon Pharmaceuticals Inc.: SG&A Expense Trends
SG&A Efficiency Analysis: Comparing Novo Nordisk A/S and Protagonist Therapeutics, Inc.
Novo Nordisk A/S vs Agios Pharmaceuticals, Inc.: SG&A Expense Trends
Breaking Down SG&A Expenses: Novo Nordisk A/S vs Dynavax Technologies Corporation
Novo Nordisk A/S and Travere Therapeutics, Inc.: SG&A Spending Patterns Compared
Novo Nordisk A/S or Taro Pharmaceutical Industries Ltd.: Who Manages SG&A Costs Better?
Breaking Down SG&A Expenses: Takeda Pharmaceutical Company Limited vs Lantheus Holdings, Inc.
Cost Management Insights: SG&A Expenses for Summit Therapeutics Inc. and Lantheus Holdings, Inc.
Comparing SG&A Expenses: Dr. Reddy's Laboratories Limited vs Lantheus Holdings, Inc. Trends and Insights
Who Optimizes SG&A Costs Better? Lantheus Holdings, Inc. or Amicus Therapeutics, Inc.
Breaking Down SG&A Expenses: Lantheus Holdings, Inc. vs Viridian Therapeutics, Inc.